(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVIDITY BIOSCIENCES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AVIDITY BIOSCIENCES

ST13

US500000088808600

Class

5, 42

Filing

88808600

Registration

7055715

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

70

Latest update

05/28/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

02/24/2020

Registration date

05/16/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/16/2023

Last transaction

05/28/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/04/2021

First use in commerce

11/04/2021

Drawing code

3

Owner type

03

Owner location

SAN DIEGO, CA, US

Examiner

KEELEY, ALISON REBECCA

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape.

Holders and representatives

Holders

ATRIUM THERAPEUTICS, INC.
Avidity Biosciences, Inc.
Avidity Biosciences, Inc.

Representatives

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biologicalmedicinal and pharmaceutical preparationsoligonucleotide-based therapeutics for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonaryneuromuscularrare muscle diseasescardiomyopathiesheart muscle diseasesmuscular dystrophiesmuscle atrophygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders

Class 42

providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Publications

History of USPTO decisions and trademark events.

70 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/27/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/05/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/05/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/05/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/05/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/05/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/05/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/05/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/05/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/05/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/05/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/16/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/16/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/13/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/04/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/04/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/04/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/30/2023

GNFR

FINAL REFUSAL E-MAILED

01/30/2023

CNFR

SU - FINAL REFUSAL - WRITTEN

01/30/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/31/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/31/2022

ALIE

ASSIGNED TO LIE

12/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/04/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/15/2022

GNRT

NON-FINAL ACTION E-MAILED

09/15/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/15/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/24/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/23/2022

EX4G

SOU EXTENSION 4 GRANTED

08/23/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/23/2022

IUAF

USE AMENDMENT FILED

08/15/2022

EXT4

SOU EXTENSION 4 FILED

08/15/2022

EEXT

SOU TEAS EXTENSION RECEIVED

08/15/2022

EISU

TEAS STATEMENT OF USE RECEIVED

08/15/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/18/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/18/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/18/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/18/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/16/2022

EX3G

SOU EXTENSION 3 GRANTED

02/14/2022

EXT3

SOU EXTENSION 3 FILED

02/14/2022

EEXT

SOU TEAS EXTENSION RECEIVED

02/14/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/28/2021

EX2G

SOU EXTENSION 2 GRANTED

07/26/2021

EXT2

SOU EXTENSION 2 FILED

07/26/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/26/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/27/2020

EX1G

SOU EXTENSION 1 GRANTED

11/25/2020

EXT1

SOU EXTENSION 1 FILED

11/25/2020

EEXT

SOU TEAS EXTENSION RECEIVED

11/25/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/25/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/30/2020

PUBO

PUBLISHED FOR OPPOSITION

06/30/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/28/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/28/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

05/28/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/28/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

05/28/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/28/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/20/2020

GNRT

NON-FINAL ACTION E-MAILED

05/20/2020

CNRT

NON-FINAL ACTION WRITTEN

05/20/2020

DOCK

ASSIGNED TO EXAMINER

05/12/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/28/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/27/2020

NWAP

NEW APPLICATION ENTERED

02/27/2020

Continuous trademark protection

Get notified about every new filing that threatens AVIDITY BIOSCIENCES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.